Efficacy of additional methotrexate as a maintenance treatment in a Japanese patient with psoriatic arthritis refractory to infliximab monotherapy

被引：1
|
作者：
Nonomura, Yumi [1 ]
Otsuka, Atsushi [1 ]
Miyachi, Yoshiki [1 ]
Kabashima, Kenji [1 ]
Tanioka, Miki [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, Kyoto 6068507, Japan
来源：
JOURNAL OF DERMATOLOGY | 2012年 / 39卷 / 11期
关键词：
COHORT;
D O I：
10.1111/j.1346-8138.2012.01548.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：954 / 955
页数：2
相关论文
共 50 条
  • [21] A pharmacogenetic study on the efficacy of methotrexate in psoriatic arthritis
    Chandran, V.
    Siannis, F.
    Schentag, C. T.
    Peddle, L.
    Pellett, F. J.
    Farewell, V.
    Rahman, P.
    Gladman, D. D.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) : 1410 - 1410
  • [22] A CLINICAL AND MAGNETIC RESONANCE IMAGING ASSESSMENT OF THE EFFICACY OF INFLIXIMAB AT A DOSE OF 3 mg/kg IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF PSORIATIC ARTHRITIS
    Marzo-Ortega, H.
    Mc Gonagle, D.
    Tan, A. L.
    Rhodes, L.
    Tanner, S.
    Conaghan, P. G.
    O'Connor, P.
    Fraser, A.
    Veale, D.
    Emery, P.
    RHEUMATOLOGY, 2004, 43 : 130 - 130
  • [23] Efficacy of methotrexate and tumor necrosis factor inhibitors in Japanese patients with active psoriatic arthritis
    Mori, Yu
    Kuwahara, Yoshiyuki
    Chiba, Shinpei
    Itoi, Eiji
    MODERN RHEUMATOLOGY, 2015, 25 (03) : 431 - 434
  • [24] METHOTREXATE TREATMENT OF PSORIATIC-ARTHRITIS
    ZACHARIAE, H
    ZACHARIAE, E
    ACTA DERMATO-VENEREOLOGICA, 1987, 67 (03) : 270 - 273
  • [25] Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients
    Feletar, M
    Brockbank, JE
    Schentag, CT
    Lapp, V
    Gladman, DD
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (02) : 156 - 161
  • [26] Efficacy and safety in the long-term treatment with infliximab of psoriasis and psoriatic arthritis
    Papoutsaki, M.
    Chimenti, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : S7 - S7
  • [27] Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: Findings of the infliximab multinational psoriatic arthritis controlled trial (IMPACT)
    Antoni, Christian E.
    Kavanaugh, Arthur
    van der Heijde, Desiree
    Beutler, Anna
    Keenan, Gregory
    Zhou, Bie
    Kirkham, Bruce
    Tutuncu, Zuhre
    Burmester, Gerd R.
    Schneider, Udo
    Furst, Daniel E.
    Molitor, Jerry
    Keystone, Edward
    Gladman, Dafna D.
    Manger, Bernhard
    Wassenberg, Siegfried
    Weier, Ralf
    Wallace, Daniel J.
    Weisman, Michael H.
    Kalden, Joachim R.
    Smolen, Josef S.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (05) : 869 - 876
  • [28] Paradoxical uveitis and pyoderma gangrenosum in a patient with psoriatic arthritis under infliximab treatment
    Fujimoto, Norihiro
    Yamasaki, Yuuki
    Watanabe, Risa
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 (09): : 1139 - 1140
  • [29] Long term treatment of psoriatic arthritis with infliximab
    Yazdani-Biuki, B
    Wohlfahrt, K
    Mulabecirovic, A
    Mueller, T
    Hermann, J
    Graninger, WB
    Brezinschek, HP
    Brezinschek, RI
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (11) : 1531 - 1532
  • [30] Abatacept Monotherapy Versus Abatacept Plus Methotrexate for Treatment-Refractory Rheumatoid Arthritis
    Pascart, Tristan
    Philippe, Peggy
    Drumez, Elodie
    Deprez, Xavier
    Cortet, Bernard
    Duhamel, Alain
    Houvenagel, Eric
    Flipo, Rene-Marc
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (03) : E358 - E363
12345